Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rafael Holdings, Inc. Class B Common Stock (NY:RFL)

1.340 -0.020 (-1.47%)
Streaming Delayed Price Updated: 2:53 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,143
Open 1.360
Bid (Size) 1.320 (900)
Ask (Size) 1.340 (100)
Prev. Close 1.360
Today's Range 1.320 - 1.360
52wk Range 1.280 - 3.190
Shares Outstanding 100
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-22.8%
-22.8%
1 Month
-2.9%
-2.9%
3 Month
-23.0%
-23.0%
6 Month
-5.0%
-5.0%
1 Year
-26.2%
-26.2%

More News

Read More
Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors
From Rafael Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)
From Rafael Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Which stocks are gapping on Wednesday?
Via Chartmill
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
From Rafael Holdings, Inc.
Via GlobeNewswire
Unusual volume stocks are being observed in Thursday's session.
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Top movers analysis in the middle of the day on 2025-06-11: top gainers and losers in today's session.
Via Chartmill
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
From Rafael Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of
From Rafael Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
From Rafael Holdings, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Rafael Holdings, Inc. Class B Common Stock publicly traded?
Yes, Rafael Holdings, Inc. Class B Common Stock is publicly traded.
What exchange does Rafael Holdings, Inc. Class B Common Stock trade on?
Rafael Holdings, Inc. Class B Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Rafael Holdings, Inc. Class B Common Stock?
The ticker symbol for Rafael Holdings, Inc. Class B Common Stock is RFL on the New York Stock Exchange
What is the current price of Rafael Holdings, Inc. Class B Common Stock?
The current price of Rafael Holdings, Inc. Class B Common Stock is 1.340
When was Rafael Holdings, Inc. Class B Common Stock last traded?
The last trade of Rafael Holdings, Inc. Class B Common Stock was at 11/03/25 02:53 PM ET
What is the market capitalization of Rafael Holdings, Inc. Class B Common Stock?
The market capitalization of Rafael Holdings, Inc. Class B Common Stock is 134.00
How many shares of Rafael Holdings, Inc. Class B Common Stock are outstanding?
Rafael Holdings, Inc. Class B Common Stock has 134 shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.